TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06719089: Evaluation of the Safety and Performance of the Hydrustent® Biodegradable Hydrogel Ureteral Stent in Patients With Nephrolithiasis: A Multicentric, Randomized, Controlled Study

Sponsor: Hydrumedical · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 134 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,872,400

Rescue Site Savings

+$4,548,400

Unlock Full NCT06719089 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06719089 Rescue Dossier →